Fund I

Its ReFlow technology addresses blocked brain shunts in hydrocephalus patients, with the goal of reducing repeat surgeries.

Gives scientists a way to measure exactly how CRISPR gene editing performs, an important step toward making genetic treatments more reliable.

Makes hard-to-see abnormalities more visible on medical images, particularly when dense breast tissue makes cancer detection difficult.

A simple cheek swab can reveal genetic information that helps doctors select more effective blood pressure medications.

Its OsteoPearl implant offers an alternative to bone cement for spinal fractures by supporting the body's natural bone-healing process.

A smartphone or computer camera can measure vital signs without a wearable device or specialized medical equipment

Expanding beyond eye-drop technology to improve how eye conditions are treated and monitored through precision medication delivery, at-home monitoring, and AI-driven insights.

Brings personalized healthcare support into patients' homes, connecting them with clinical services and guidance based on their medical needs.

Makes medical billing and payments easier for patients while helping healthcare providers collect payments faster, reduce costs, and spend less time chasing unpaid bills.

Gives breast cancer surgeons detailed 3D views of tumors to better understand each patient's cancer and plan treatment.

Its Wave Health platform captures what cancer patients experience between appointments, giving care teams a clearer picture of symptoms and treatment effects.

Brings patient-specific medical and social information into clinical decisions to address gaps and inequities in care.